By John Schroyer and Bart Schaneman

The launch of Maine’s recreational marijuana industry is delayed, a deadline passes for Maryland’s licensed medical cannabis growers, and the Department of Justice nixes a DEA decision on MJ research.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

John Schroyer  |
August 18, 2017

Washington state rule change expands business options for marijuana cultivators

Bart Schaneman  | August 17, 2017

By Bart Schaneman

Washington state recently eased restrictions on how many producer licenses marijuana businesses can own, a move that could lead to more competition, an uptick in mergers and acquisitions and possibly increased supply.

Under the state’s revised policy, business owners can up their licenses from one to three, effective immediately.

Bart Schaneman  |
August 17, 2017

By Matt Lamers

Canadian medical marijuana producer Tilray will invest 30 million Canadian dollars ($24 million) to convert an Ontario pepper farm into one of the nation’s largest MJ production facilities.

The project’s initial phase will give Tilray a fivefold increase in production capacity to over 40,000 kilograms a year by the end of 2018.

Matt Lamers  |
August 17, 2017

Several factors led to Hawaii’s flawed medical marijuana launch

Bart Schaneman  | August 16, 2017

By Bart Schaneman

When Hawaii's two operational medical marijuana dispensaries were forced to close just days after opening, a laboratory bottleneck was blamed for a supply disruption.

But participants in the fledgling MMJ program said the state's only functioning lab isn't at fault. Instead, they pointed to a number of other factors for their problems.

Bart Schaneman  |
August 16, 2017

Canadian execs: What you need to know before taking your cannabis business global

Matt Lamers  | August 16, 2017

By Matt Lamers

There’s no denying the massive potential of the global medical marijuana market: A recent report pegged it at 180 billion Canadian dollars ($142 billion) over the next 15 years.

But going overseas is fraught with pitfalls, barriers and red tape. Canadian MMJ businesses, however, are export pioneers and can offer valuable guidance.

Matt Lamers  |
August 16, 2017

Marijuana industry may be tiring of playing the ‘strain name game’

Omar Sacirbey  | August 15, 2017

By Omar Sacirbey

Many marijuana businesses sell goods based on strain names, but those days could be coming to an end.

More industry participants seemingly are starting to view strain names as unreliable indicators of a plant’s genetics and what types of cannabinoids are actually present in marijuana products.

Omar Sacirbey  |
August 15, 2017

Canadian exports of medical marijuana soar as producers seek overseas toehold

Matt Lamers  | August 15, 2017

By Matt Lamers

Canadian medical cannabis exports are surging, driven by licensed producers that are using overseas shipments as a way to establish local partnerships and gain a foothold in foreign markets.

In particular, exports of dried medical marijuana and MMJ oil products from Canada have soared since 2015.

Matt Lamers  |
August 15, 2017

Week in Review: Nevada marijuana promotions, MMJ banking in Florida & Sessions’ letters

Bart Schaneman  | August 11, 2017

By Bart Schaneman and Omar Sacirbey

A Nevada regulator threatens crackdowns on marijuana promotions, a bank in Florida is openly working with MMJ businesses, and U.S. Attorney General Jeff Sessions writes letters to governors of three recreational cannabis states.

Here’s a closer look at some notable developments in the marijuana industry over the past week.

Bart Schaneman  |
August 11, 2017

News Briefs